The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro

Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1

Abstract

Purpose of investigation: The pleiotropic factor Y-box binding protein-1 (YB-1) is clinically correlated with breast cancer patients’ poor outcome. Due to the intereference of YB-1 with the estrogen receptor, the authors examined the antiproliferative efficacy of 4-hydroxytamoxifen (4-OHT) and fulvestrant (FUL) in the presence of low and high levels of YB-1. Materials and Methods: The human breast cancer cell line MCF-7 was transfected to overexpress YB-1 protein. 4- OHT and FUL incubation experiments were performed and cell growth behaviour of YB-1 overexpressing MCF-7 cells were compared to unmodified MCF-7 cells expressing endogenous YB-1 levels. Results: The incubation of MCF-7 cells with 100 nM 4-OHT and 1 nM FUL over a period of 120 hours clearly demonstrated the antiproliferative properties of both antiestrogens as expected. Notably, high levels of YB-1 led to an increase of antiproliferative properties in the presence of 4-OHT and FUL. Conclusion: The data presented here demonstrated YB-1 enhances the antiestrogenic efficacy of 4- OHT and FUL. Thus, the group of high level YB-1 mamma carcinoma patients might increasingly benefit from endocrine therapy.

Authors and Affiliations

M. B. Stope, M. Weiss, S. L. Popp, C. Joffroy, A. Mustea, S. Brucker, D. Wallwiener

Keywords

Related Articles

Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding

Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additio...

Diffusion magnetic resonance in cervical carcinoma: the role of apparent diffusion coefficient in the evaluation of treatment response

Purpose: The aim of the study was to determinate the role of apparent diffusion coefficient (ADC) in order to find cut-off values in the evaluation of treatment response. Materials and Methods: A retrospective study was...

Resource utilisation and cost of cervical cancer and dysplasia in Croatia

Purpose of investigation: To analyse resource utilisation and costs due to cervical cancer and dysplasia in Croatia. Materials and Methods: Patients diagnosed with cervical cancer were identified from the Croatian Nation...

Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer

Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitone...

Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR

Purpose of investigation: To establish the relationship between high-risk human papillomavirus (hrHPV) serotypes and the odds of developing cervical intraepithelial lesions. Material and Methods: Retrospective cohort stu...

Download PDF file
  • EP ID EP626296
  • DOI 10.12892/ejgo4282.2019
  • Views 40
  • Downloads 0

How To Cite

M. B. Stope, M. Weiss, S. L. Popp, C. Joffroy, A. Mustea, S. Brucker, D. Wallwiener (2019). The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro. European Journal of Gynaecological Oncology, 40(1), 16-18. https://europub.co.uk/articles/-A-626296